Saturday 9 February 2019

The Global Hemp Marketplace


Farm Bill 2018 special reports that "Roughly 30 countries in Asia, Europe, and North and South America already allow hemp cultivation".

The United Nations’ Food and Agriculture Organiszation, which tracks global farming, reports that "Global acreage in hemp cultivation in 2016—the most recent year available—was 192,000 acres. The U.N. estimated total hemp production in 2016 at 355 million pounds".
But those numbers are incomplete.Not all nations report hemp acreage to the U.N. 

 Among the producers left out of the U.N.’s hemp count: 
• Canada, where industry groups say about 138,000 acres of hemp were planted in 2018.
• Uruguay, where 2,471 acres of hemp were licensed in 2018.
• Colombia, where acreage counts are not available. With those exceptions, global acreage in hemp cultivation in 2016 was 192,000 acres, with total production of 355 million pounds. Leading hemp producers are:
• *European Union
• China
• South Korea
• Russia
(*Most production takes place in France, the Netherlands, Lithuania and Romania.) Many of the Latin American countries that have been developing cannabis legislation have been cautious to allow cultivation and started with restrictive, import-only programs of CBD products—which opens the door for new hemp producers to enter the market.
These include:
• Brazil
• Argentina
• Paraguay
• Mexico
But legislation is evolving rapidly, and only Brazil has no plans in place to eventually allow cultivation.

Global investment 

The Farm Bill is certain to trigger a global shift in cannabis investing. That’s because U.S.-based hemp companies now have full access to the largest and most prestigious exchanges, Nasdaq and the New York Stock Exchange. Will Wall Street create hemp giants that will leverage their capital and competitive edge overseas? According to Preston Gardner, an analyst with CVC Partners, U.S. hemp investors should expect:
• Significant M&A activity.
• Hemp activity in the agricultural, pharmaceutical and technology industries.
• American hemp companies seeking a global edge through quality control. 

The last point could be the best way for U.S. hemp entrepreneurs to compete against larger hemp producers around the globe. “Our cost to cultivate is going to be greater compared with international competitors,” Gardner said. He believes American hemp producers will tout “a quality differentiation factor,” particularly their expertise cultivating high-CBD cultivars. 

Instituting quality considerations, such as Good Manufacturing Practice and standard operating procedures, will be key for American hemp to find markets overseas. 
For Free download the Farm Bill 2018 Special Report :
https://hempindustrydaily.com

Wednesday 6 February 2019

World Health Organization Recommends Reclassifying Marijuana Under International Treaties


Global health experts at the United Nations are recommending that marijuana and its key components be formally rescheduled under international drug treaties.
The World Health Organization (WHO) is calling for whole-plant marijuana, as well as cannabis resin, to be removed from Schedule IV—the most restrictive category of a 1961 drug convention signed by countries from around the world.

Sunday 3 February 2019

Cannabis Oil In Israeli Autism Study Has 90% Success Rate!

Israeli medical cannabis firm, Tikun Olam, has completed autism clinical trial with CBD-rich Avidekel cannabis oil. The results are very hopeful for autism patients.

Media images of sick children taking cannabis oil brought medical cannabis to the mainstream. Often, the most extreme cases made the biggest impacts—Charlotte FigiAlyssa ErwinHaleigh Cox. While most families will never endure the trials of caring for a child with Dravet syndrome, brain cancer, or cerebral palsy, one condition could hit close to home: autism. Fortunately, the Avidekel chemovar by Tikun Olam is proven effective in treating symptoms of autism in recent clinical trial.

How Monsanto shuts down your kidneys, liver, brain, and immune system



A recently released “state of the science” review by the Pesticide Action Network International (PAN) contains a wealth of research that documents the adverse environmental and human health impacts of glyphosate and glyphosate-based herbicides.  The review’s findings emphasize the need for these compounds to be permanently phased out.

Health and environmental advocates say the monopoly on what has become the world’s most-used herbicide – which is the primary ingredient in Monsanto’s Roundup – ought to be a wake-up call for governments, regulatory agencies and farmers around the world who use it.

Saturday 2 February 2019

Chemotherapy Side Effects: Cannabinoids and CBD Research Overview

Chemotherapy can cause several, sometimes debilitating, side effects. Studies have shown cannabinoids can make the adverse effects more manageable.
Chemotherapy is a category of cancer treatment that uses strong drugs, administered orally or intravenously.

There are more than 100 chemotherapy drugs that are used in the treatment of cancer. The drugs prevent cancer from spreading to other parts of the body, slow the growth of tumors, and kill cancer cells.




While chemotherapy can be effective against cancer, it does cause sometimes-serious side effects.


Overview of Chemotherapy Side Effects
The side effects from chemotherapy develop because the chemotherapy drugs that attack cancerous cells also damage normal, healthy cells. Common side effects associated with chemotherapy are fever and chills, fatigue, nausea and vomiting, sore mouth, diarrhea, constipation, loss of appetite that can lead to anorexia, pain or difficulty with swallowing, swelling in the hands or feet, itching, shortness of breath, cough, and muscle or joint pain.

Individuals undergoing chemotherapy won’t necessarily experience all side effects and the severity of the side effects varies greatly from person to person. Most side effects will gradually go away after completion of the treatment.
Effects of Cannabinoids and CBD on Chemotherapy Side Effects
Cannabinoids have shown to effectively reduce the nausea and vomiting that often occurs during and after chemotherapy treatments. Studies have found that one of the major cannabinoids found in cannabis, cannabidiol (CBD), is effective at treating the more difficult to control symptoms of nausea, as well as preventing anticipatory nausea in chemotherapy patients. Another study found that tetrahydrocannabinol (THC), another major cannabinoid found in cannabis, is also effective at reducing conditioned rejection and chemotherapy-induced nausea.